Abstract
The identification of evidence-based, efficacious drug combinations for each cancer, among thousands of potential permutations, is a daunting task. In this perspective, we propose a systematic approach to defining such combinations by molecularly benchmarking a drug against a desired state of efficacy using model systems.
Original language | English (US) |
---|---|
Pages (from-to) | 1339-1344 |
Number of pages | 6 |
Journal | Cancer discovery |
Volume | 3 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2013 |
ASJC Scopus subject areas
- Oncology